Log in · Sign up
ELEVANCE HEALTH, INC. (ELV) reported Stock-based compensation of USD 210,000,000 for the period from 2026-01-01 to 2026-09-30 in its 10-Q (accession 0001156039-26-000071, filed 2026-10-21).
| Period | Value | Verify |
|---|---|---|
| 2026-01-01 ~ 2026-09-30 | $210,000,000 | EDGAR ↗ |
| 2025-09-30 (comparative) | $246,000,000 | EDGAR ↗ |
Company ELEVANCE HEALTH, INC. · CIK 1156039
Form 10-Q · Accession 0001156039-26-000071 · Filed 2026-10-21
XBRL tag us-gaap:ShareBasedCompensation · unit USD · duration
Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.
ELEVANCE HEALTH, INC. (ELV) reported Stock-based compensation of USD 210,000,000 for the period from 2026-01-01 to 2026-09-30 in its 10-Q (accession 0001156039-26-000071, filed 2026-10-21).
— aiSwingX, https://aiswingx.com/n/0001156039-26-000071/ShareBasedCompensation
JSON: /api/v1/facts/0001156039-26-000071/ShareBasedCompensation